Industry NewsMaze Therapeutics announces Phase 1 trial initiation evaluating MZE001 as a potential oral treatment for Pompe Disease
Industry NewsImmutep granted Australian patent for Eftilagimod Alpha in combination with a PD-1 pathway inhibitor
Industry NewsPerkinElmer to showcase expanded life science/cell & gene therapy portfolios and automated genomic workflows at SLAS 2022
Industry NewsNanoparticle-formulated drug combination is effective in medulloblastoma, a pediatric brain tumor